Nick Morrell

ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport academic.oup.com/cardiovascres/… Great to see this out. Wonderful collaboration with @PeterVangheluwe and team!

We have had lots of fun this morning celebrating the announcement of a £16 million gift to HLRI and are thrilled to change our name in honour of our generous benefactor. We are grateful to Victor & our other wonderful partners incl @TheBHF @papworthcharity @cftrust @wolfsonfdn

We are delighted to announce that today we have become the Victor Phillip Dahdaleh Heart & Lung Research Institute to honour a very generous philanthropic donation from @victordahdaleh @Cambridge_Uni @RoyalPapworth @CUHPartners

Join Centessa and the Rare Disease community to help raise awareness of #RareDisease. Show your stripes in honor of #RareDiseaseDay and visit @RareDisease's website to get involved: bit.ly/3ZRqSFx

A lifetime pleasure to give a plenary talk at my home conference #winterBTS2022

Centessa hosted @PHAssociation & individuals living with PH for an event to raise awareness of this complex disease. Learn how you can help spread awareness #PulmonaryArterialHypertension.

Proud moment! My First, First Author paper is finally published! Happy Monday News! 🥳 An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis ➡️nature.com/articles/s4200… @CommsBio #PAH #PhD #PhDChat Here's the Tweetorial👇

Amazing Accomplishment: our first joint paper is published in Blue Journal @ATSBlueEditor !! Huge Thanks to all contributors and especially to Justyna Karolak for the leadership! Big research value, but also huge increase of credibility for TBX4Life! #tbx4 atsjournals.org/doi/abs/10.116…

Today we announced that new data from an additional 18-months of continued treatment with SerpinPC from the OLE of our Phase 2a Study of SerpinPC in hemophilia was accepted for oral presentation at the 64th ASH Annual Meeting on Sat., Dec. 10 at 2:15pm CT. investors.centessa.com/news-releases/…

It's #PulmonaryHypertension Awareness Month. Centessa's advancing MGX292 as part of our mission to develop transformational medicines for patients with #PulmonaryArterialHypertension. Visit @PHAssociation to learn more about PH Awareness month: bit.ly/3De9YGN

Great job of the International Consortium for Genetic Studies in PAH. Proud to be part of this dynamic team. @Pulmotension @Respifil @InsermU999 Genetic counselling and testing in pulmonary arterial hypertension - A consensus statement erj.ersjournals.com/content/early/…

Today we announced a poster presentation of data from our oral small-molecule orexin receptor 2 (OX2R) agonist discovery pipeline at #SleepEurope 2022. The poster will be presented in Athens on Thurs., Sept. 29 at 12:15pm EEST. Read our press release: investors.centessa.com/news-releases/…

@DrWillWatson @charlot_summers @Cambridge_Uni @RoyalPapworth @CUHPartners @CUH_NHS 😂 🤣

@Morphogen_IX @charlot_summers @Cambridge_Uni @RoyalPapworth @CUHPartners @CUH_NHS Professor Morrell will lie in state in seminar room 1.01 for the next 4 days.

I'm delighted to share that I've been appointed as the Interim Director of the Heart and Lung Research Institute. I will be taking over from @Morphogen_IX in Oct & doing my best not to ruin his many years of hard work! #HLRI @Cambridge_Uni @RoyalPapworth @CUHPartners @CUH_NHS

Thrilled to announce that US Orphan Drug designation was granted to SerpinPC, our novel inhibitor of activated protein C, being investigated as a treatment of #hemophiliaB. We look forward to initiating registrational studies for SerpinPC later this year. bit.ly/3eDNx50

LockBody is hiring! Looking for talented, passionate scientists who want to change the future of cancer therapy: centessa.com/career-details/

Today is a historic day for @TheBHF, as we announce #CureHeart as the winner of our £30m #BigBeatChallenge 🔬 I'm unbelievably proud that this incredible research, funded by our amazing supporters, could lead to the first cures for people with inherited muscle heart diseases

@SnupSnus That's the one: nature.com/articles/news.…

@Morphogen_IX Is this the one that lives (or feeds?) on birch and when pollution was really bad developed the black spots to regain its camouflage? for sure looks like it could be the one

The peppered moth - never actually seen one in real life before (although this one sadly dead). One of the first evolutionary stories we heard at school featured this beautiful creature.